2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations

Date: July 27, 2014
Pages: 1200
Price:
US$ 34,500.00
License [?]:
Publisher: Venture Planning Group
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: 228E2306ABBEN
Leaflet:

Download PDF Leaflet

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
Complete report $34,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100. The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations” is Venture Planning Group’s new study of the major business opportunities emerging in the global cancer diagnostics market during the nextfive years. The report examines trends in the U.S., Europe and Asia; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

Geographic Coverage

France, Germany, Italy, Japan, Spain, UK, USA

Worldwide Market Overview
  • Five-year test volume and sales projections by country.
  • Comprehensive Market Segmentation Analysis, including review of the market dynamics, structure, size, growth and major suppliers by country.
  • Estimated universe of laboratories performing cancer diagnostic testing by country.
  • Cancer statistics, etiology and recent developments in the U.S., Europe, and Asia.
Business Opportunities and Strategic Recommendations
  • Specific new product development opportunities with potentially significant market appeal during the next five years.
  • Design criteria for new products.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
Over 200 Current and Emerging Cancer Diagnostic Test
  • Oncogenes
  • Biochemical Markers
  • Growth Factors
  • Colony Stimulating Factors
  • Hormones
  • Immunohistochemical Stains
  • Lymphokines
Supplier Shares, Sales and Volume Forecasts
  • Sales and market shares of major cancer diagnostic product suppliers by individual test and country.
  • Five-year test volume and sales forecasts for major tumor markers by country and market segment, including:
    • Hospitals
    • Commercial/Private Laboratories
    • Physician Offices/Group Practices
    • Cancer Clinics
    • Ambulatory Care Centers
Instrumentation Review

Analysis of major molecular diagnostic and immunodignostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

Technology Assessment
  • Assessment of latest technologies and their potential applications for cancer diagnostic testing.
  • Review of competing/complementing technologies.
  • Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.
Competitive Strategies

Strategic assessments ofmajor suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

The companies analyzed in the report include:
  • Abbott
  • AdnaGen
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca/Nuvelo
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Correlogic Systems/Vermillion
  • Decode
  • Diadexus
  • Diagnocure
  • DiaSorin
  • Eiken Chemical
  • Epigenomics
  • Enterix
  • Enzo Biochem
  • Exact Sciences
  • Fujirebio/Innogenetics
  • Guided Therapeutics
  • Hologic/Gen-Probe
  • Kreatech
  • Kyowa Medex
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen/Ipsogen
  • Quest Diagnostics
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagnostics & Therapeutics
  • Thermo Fisher/Life Technologies
  • Tosoh
  • Veridex
  • Wako Pure Chemicals
  • Wallac/PE
  • Zilla
Contains 1,200 pages and 450 tables
I. Introduction

II. Worldwide Market Overview

A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth

III. Major Product Development Opportunities

A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies

VI. Potential Market Entry Barriers and Risks

VII. Worldwide Market and Technology Overview

A. Major Current and Emerging Cancer Diagnostic Tests
  1. BIOCHEMICAL TUMOR MARKERS
  2. ONCOGENES
  3. POLYPEPTIDE GROWTH FACTORS
  4. ECTOPIC HORMONES
  5. COLONY STIMULATING FACTORS
  6. LYMPHOKINES
  7. IMMUNOHISTOCHEMICAL STAINS
  8. EMERGING TUMOR MARKERSTABLE OF CONTENTS
B. Instrumentation Review and Market Needs
C. Current and Emerging Technologies
D. Personal Testing

VIII. France

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
  Volume Forecasts by Test and Market Segment
  Sales Forecasts by Test and Market Segment
  Major Supplier Sales and Market Shares

IX. Germany

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
  Volume Forecasts by Test and Market Segment
  Sales Forecasts by Test and Market Segment
  Major Supplier Sales and Market Shares

X. Italy

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
  Volume Forecasts by Test and Market Segment
  Sales Forecasts by Test and Market Segment
  Major Supplier Sales and Market SharesTable of Contents

XI. Japan

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
  Volume Forecasts by Test and Market Segment
  Sales Forecasts by Test and Market Segment
  Major Supplier Sales and Market Shares

XII. Spain

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
  Volume Forecasts by Test and Market Segment
  Sales Forecasts by Test and Market Segment
  Major Supplier Sales and Market Shares

XIII. U.K.

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
  Volume Forecasts by Test and Market Segment
  Sales Forecasts by Test and Market Segment
  Major Supplier Sales and Market Shares

XIV. U.S.A.

A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
  Volume Forecasts by Test and Market Segment
  Sales Forecasts by Test and Market Segment
  Major Supplier Sales and Market SharesTable of Contents

XV. Competitive Profiles

Abbott
AdnaGen
Agilent Technologies
Applied Gene Technologies
Arca/Nuvelo
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
Bio-Rad
CellSearch
Cepheid
Correlogic Systems/Vermillion
Decode
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Epigenomics
Enterix
Enzo Biochem
Exact Sciences
Fujirebio/Innogenetics
Guided Therapeutics
Hologic/Gen-Probe
Kreatech
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
Nanogen Elitech
OncoLab
Ortho-Clinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen/Ipsogen
Quest DiagnosticsTable of Contents
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Thermo Fisher/Life Technologies
Tosoh
Veridex
Wako Pure Chemicals
Wallac/PE
Zila

XVI. Appendix: Major Universities and Research

Centers Developing Cancer Diagnostic
Technologies and Applications

List of Tables

Cancer Diagnostic Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Sub classification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
Executive Summary Table:
France, Total Cancer Diagnostic Testing Volume and Sales Forecasts by Market Segment
France, Estimated Cancer Death Rates
France, Laboratories Performing Cancer Diagnostic Tests by Market Segment
France, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
France, Commercial/Private Laboratories Performing Cancer Diagnostic Test by Annual Test Volume
France, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
France, All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
France, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts by Test
France, Commercial/Private Laboratories Marker Test Volume Forecasts
France, Total Cancer Diagnostic Sales Major Cancer Diagnostic Forecasts by Market Segment
France, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
France, Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
France, Commercial/Private Laboratories Cancer Diagnostic Market Forecasts by Test
France, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
France, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
France, CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market
France, CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Cathepsin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
France, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Interferons Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Interleukins Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecasts by Market Segment
France, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Nucleolar Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
France, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Progesterone Receptor Test Volume And Diagnostics Sales Forecasts by Market Segment
France, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
France, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
France, S-100 Protein Test Volume and Sales Diagnostics Sales Forecasts by Market Segment
France, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
France, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Thymidine Kinase Test Volume And Diagnostics Sales Forecasts by Market Segment
France, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
France, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
France, Total Cancer Diagnostics Sales By Major Suppliers
France, AFP Testing Market Diagnostics Sales by Major Supplier
France, CA 15-3 Testing Market Diagnostics Sales by Major Supplier
France, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
France, CA 125 Testing Market Diagnostics Sales by Major Supplier
France, CEA Testing Market Diagnostics Sales by Major Supplier
France, NSE Testing Market Diagnostics Sales by Major Supplier
France, PAP Testing Market Diagnostics Sales by Major Supplier
France, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table:
Germany, Total Cancer Diagnostic Testing Volume and Sales Forecasts by Market Segment
Germany, Estimated Cancer Death Rates
Germany, Laboratories Performing Cancer Diagnostic Tests by Market Segment
Germany, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
Germany, Commercial/Private Laboratories Performing Cancer Diagnostic Tests by Annual Test Volume
Germany, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
Germany, All Market Segments, Major Cancer Diagnostic Test Volume Forecasts by Test
Germany, Hospital Laboratories, Major Cancer Diagnostic Test Volume Forecasts by Test
Germany, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
Germany, Physician Offices/Group Practices Major Cancer Diagnostic Test Volume Forecasts
Germany, Total Cancer Diagnostic Sales Forecasts by Market Segment
Germany, All Market Segments Major Tumor Marker Sales Forecasts by Test
Germany, Hospital Laboratories, Major Tumor Marker Sales Forecasts by Test
Germany, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
Germany, Physician Offices/Group Practices Major Cancer Diagnostic Sales Forecasts by Test
Germany, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecasts by Market Segment
Germany, CA-15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, CA-19 Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, CA 125 Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Calcitonin Test Volume And Diagnostic Sales Forecasts by Market Segment
Germany, Cathepsin Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Chromogranin Test Volume And Diagnostics Sales Forecasts by Market Segment
Germany, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
Germany, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, HCG, Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Interferons Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Interleukins Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Pap Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Progesterone Receptor Test Volume And Diagnostics Sales Forecasts by Market Segment
Germany, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, S-100 Protein Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
Germany, Total Cancer Diagnostics Sales By Major Supplier
Germany, AFP Testing Market Diagnostics Sales by Major Supplier
Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier
Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
Germany, CEA Testing Market Diagnostics Sales by Major Supplier
Germany, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table:
Italy, Total Cancer Diagnostic Testing Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Estimated Cancer Death Rates
Italy, Laboratories Performing Cancer Diagnostic Tests by Market Segment
Italy, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
Italy, Commercial/Private Laboratories Performing Cancer Diagnostics Tests by Annual Test Volume
Italy, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
Italy, All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
Italy, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts
Italy, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
Italy, Total Cancer Diagnostic Test Market Forecasts by Market Segment
Italy, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
Italy, Hospital Laboratories Major Cancer Diagnostic Forecasts by Test
Italy, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
Italy, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecasts by Market Segment
Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, CA-19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, CA 125 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Chromogranin Test Volume And Diagnostics Sales Forecasts by Market Segment
Italy, Colon Specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
Italy, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecasts by Market Segment
Italy, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts By Market Segment
Italy, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, S-100 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Total Cancer Diagnostics Sales by Major Suppliers
Italy, AFP Testing Market Diagnostics Sales by Major Supplier
Italy, CEA Testing Market Diagnostics Sales by Major Supplier
Italy, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table:
Japan, Total Cancer Diagnostic Testing Volume and Sales Forecasts By Market Segment
Japan, Estimated Cancer Death Rates
Japan, Laboratories Performing Cancer Diagnostic Tests by Market Segment
Japan, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
Japan, Commercial/Private Laboratories Performing Cancer Diagnostic Tests by Annual Test Volume
Japan, Total Cancer Diagnostic Testing Volume Forecasts by Market Segment
Japan, All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
Japan, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts by Test
Japan, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
Japan, Total Cancer Diagnostic Sales Forecasts by Market Segment
Japan, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
Japan, Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
Japan, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
Japan, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Cathepsin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Chromogranin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
Japan, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Interferons Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Interleukins Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Nucleolar Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, S-100 Protein Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, TPA, Test Volume and Diagnostics Sales Forecasts by Market Segment
Japan, Total Cancer Diagnostics Sales by Major Suppliers
Japan, AFP Testing Market Diagnostics Sales by Major Supplier
Japan, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Japan, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
Japan, CA 125 Testing Market Diagnostics Sales by Major Supplier
Japan, Calcitonin Testing Market Diagnostics Sales by Major Supplier
Japan, PAP Testing Market Diagnostics Sales by Major Supplier
Japan, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table:
Spain, Total Cancer Diagnostic Testing Volume and Sales Forecasts by Market Segment
Spain, Estimated Cancer Death Rates
Spain, Laboratories Performing Cancer Diagnostic Tests by Market Segment
Spain, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
Spain, Commercial/Private Laboratories Performing Cancer Diagnostics Tests by Annual Test Volume
Spain, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
Spain, All Market Segment Major Cancer Diagnostic Test Volume Forecasts
Spain, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts by Test
Spain, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
Spain, Total Cancer Diagnostic Sales Forecasts by Market Segment
Spain, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
Spain, Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
Spain, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
Spain, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, CA 15-3 Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Parathyroid Hormone Test Volume And Diagnostics Sales Forecasts by Market Segment
Spain, Progesterone Receptor Test Volume and Diagnostics Sales Forecasts By Market Segment
Spain, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, S-100 Protein Test Volume And Diagnostics Sales Forecasts by Market Segment
Spain, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
Spain, Total Cancer Diagnostics Sales By Major Suppliers
Spain, AFP Testing Market Diagnostics Sales by Major Supplier
Spain, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
Spain, 19-9 Testing Market Diagnostics Sales by Major Supplier
Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier
Spain, CEA Testing Market Diagnostics Sales by Major Supplier
Spain, PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table:
U.K., Total Cancer Diagnostic Testing Volume and Sales Forecasts by Market Segment
U.K., Estimated Cancer Death Rates
U.K., Laboratories Performing Cancer Diagnostic Tests by Market Segment
U.K., Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
U.K., Commercial/Private Laboratories Performing Cancer Diagnostic Tests By Annual Test Volume
U.K., Total Cancer Diagnostic Testing Volume Forecasts by Market Segment
U.K., All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
U.K., Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts by Test
U.K., Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
U.K., Total Cancer Diagnostic Sales Forecasts by Market Segment
U.K., All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
U.K., Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
U.K., Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
U.K., ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Chromogranin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Colon-Specific Antigen Test Volume And Diagnostics Sales by Market Segment
U.K., Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., S-100 Protein Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
U.K., Total Cancer Diagnostics Sales and Market Shares Forecasts
U.K., CEA Testing Market Diagnostics Sales by Major Supplier
U.K., PSA Testing Market Diagnostics Sales by Major Supplier
Executive Summary Table:
U.S., Total Cancer Diagnostic Testing Volume and Sales Forecasts By Market Segment
U.S., Estimated New Cancer Cases and Deaths
U.S., Estimated Cancer Death Rates
U.S., Laboratories Performing Cancer Diagnostic Tests by Market Segment
U.S., Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
U.S., Commercial/Private Laboratories Performing Cancer Diagnostic Tests by Annual Test Volume
U.S., Physician Office Laboratories Performing Cancer Diagnostic Tests By Practice Size
U.S., Total Cancer Diagnostic Test Volume Forecasts by Market Segment
U.S., All Market Segments Major Cancer Diagnostic Test Volume Forecasts
U.S., Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts by Test
U.S., Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
U.S., Physician Offices/Group Practices Major Cancer Diagnostic Test Volume Forecasts
U.S., Cancer Clinics Major Cancer Diagnostic Test Volume Forecasts by Test
U.S., Total Cancer Diagnostic Sales Forecasts by Market Segment
U.S., All Market Segment Major Cancer Diagnostic Sales Forecasts by Test
U.S., Hospital Laboratories Major Cancer Diagnostic Sales Forecasts by Test
U.S., Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
U.S., Physician Offices/Group Practices Major Cancer Diagnostic Sales Forecasts by Test
U.S., Cancer Clinics Major Tumor Marker Sales Forecasts by Test
U.S., ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., CA 19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., CA-125 Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Cathepsin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., CEA Test Volume and Diagnostics Sales by Market Segment
U.S., Chromogranin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Colon-specific Antigen Test Volume And Diagnostics Sales Forecasts by Market Segment
U.S., Cytokeratins Test Volume And Diagnostics Sales Forecasts by Market Segment
U.S., Estrogen Receptor Test Volume And Diagnostics Sales Forecasts by Market Segment
U.S., Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Interferons Test Volume And Diagnostics Sales Forecasts by Market Segment
U.S., Interleukins Test Volume And Diagnostics Sales Forecasts by Market Segment
U.S., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Nucleolar Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Occult Blood Test Volume And Diagnostics Sales Forecasts by Market Segment
U.S., Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., S-100 Protein Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
U.S., Total Cancer Diagnostics Sales By Major Supplier
U.S., ACTH Testing Market Diagnostics Sales by Major Supplier
U.S., AFP Testing Market Diagnostics Sales by Major Supplier
U.S., Beta-2 Migroblolulin Testing Market Diagnostics Sales by Major Supplier
U.S., CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
U.S., CA 19-9 Testing Market Diagnostics Sales by Major Supplier
U.S., CA 125 Testing Market Diagnostics Sales by Major Supplier
U.S., CEA Testing Market Diagnostics Sales by Major Supplier
U.S., Ferritin Testing Market Diagnostics Sales by Major Supplier
U.S., HCG Testing Market Diagnostics Sales by Major Supplier
U.S., Insulin Testing Market Diagnostics Sales by Major Supplier
U.S., Parathyroid Hormone Testing Market Diagnostics Sales by Major Supplier
U.S., PAP Testing Market Diagnostics Sales by Major Supplier
U.S., Progesterone Receptor Testing Market Diagnostics Sales by Major Supplier
U.S., PSA Testing Market Diagnostics Sales by Major Supplier

Ask Your Question

2014 Market Segmentation Analysis of the Global Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals, Commercial Labs, POC Locations
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: